Antibody-drug conjugates targeting EGFR ligand Epiregulin inhibit colorectal tumor growth irrespective of RAS mutational status
Joan Jacob, Yasuaki Anami, Peyton High, Zhengdong Liang, Shraddha Subramanian, Sukhen C. Ghosh, Solmaz AghaAmiri, Cara Guernsey, Ha Tran, Qingyun J. Liu, Julie H. Rowe, Ali Azhdarinia, Kyoji Tsuchikama, Kendra S. Carmon
bioRxiv 2024.02.20.581056; doi: https://doi.org/10.1101/2024.02.20.581056